Why Neovasc Shares Are Trading Higher Today
Neovasc Inc. (NASDAQ: NVCN) shares are trading higher after ShockWave Medical, Inc. (NASDAQ: SWAV) announced it would acquire the company.
Enzo Biochem Has Been Granted U.S. Patent Number 11,554,111 Titled “Sphingosine Pathway Modulating Compounds For The Treatment Of Coronavirus Infection”.
https://ppubs.uspto.gov/pubwebapp/external.html?q=(11554111).pn
‘Provention Bio’s Recently Approved Drug Tzield (Teplizumab) For The Delay Of Clinical Type 1 Diabetes Has Been Added To The Department Of Veterans Affairs National Acquisition Center Drug Catalog’
https://www.vendorportal.ecms.va.gov/NAC/Pharma/Details?NDC=73650031601&CNT=36F79723D017E
Biomea Fusion Doses First Patient In Phase I/Ib Clinical Trial Of BMF-219 In KRAS Mutant Solid Tumors
BMF-219 is the first menin inhibitor to be clinically studied in patients with KRAS-mutated non-small cell lung cancer (NSCLC), colorectal cancer (CRC) and pancreatic ductal adenocarcinoma (PDAC)
A pan-KRAS inhibitor
Lantern Pharma Receives Pre-IND Feedback From The FDA, Clearing A Path For Drug Candidate LP-184’s Phase 1 Clinical Trial In Q2 2023
Lantern Pharma Inc. (NASDAQ:LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") and machine learning (“M.L.”) platform to transform the
Avalo Announces It Has Completed Targeted Enrollment Of 80 Patients In Phase 2 PEAK Trial Of AVTX-002 In Non-Eosinophilic Asthma
Avalo Therapeutics, Inc. (NASDAQ:AVTX), today announced that it completed enrollment of the 80 patients targeted for the Phase 2 PEAK Trial evaluating AVTX-002 (anti-LIGHT mAb) in patients with Non-Eosinophilic Asthma
First Wave BioPharma Provides Update On IND Filing For Phase 2 Trial Of Enhanced Microgranule Formulation Of Adrulipase For Exocrine Pancreatic Insufficiency
First Wave BioPharma, Inc. (NASDAQ:FWBI) ("First Wave BioPharma" or the "Company"), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies
‘Chair Rodgers Statement On COVID-19 Vaccine Safety Signal’
https://republicans-energycommerce.house.gov/posts/chair-rodgers-statement-on-covid-19-vaccine-reports
House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA) issued the following statement after